13.06
-0.17
(-1.28%)
As of 11:52:35 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Dec 2022) | Current Year (1970) | Next Year (2023) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -22.5 | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Dec 2022) | Current Year (1970) | Next Year (2023) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 9/30/2021 | 12/31/2021 | 3/31/2022 | 6/30/2022 |
|---|---|---|---|---|
| EPS Est. | -22.5 | -21 | -10.5 | -6 |
| EPS Actual | -40.5 | -22.5 | -10.5 | -8.3 |
| Difference | -18 | -1.5 | 0 | -2.3 |
| Surprise % | -80.00% | -7.14% | 0.00% | -38.33% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Dec 2022) | Current Year (1970) | Next Year (2023) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Dec 2022) | Current Year (1970) | Next Year (2023) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | -- | 1 |
| Up Last 30 Days | -- | 1 | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| XCUR | -- | -- | -- | -- |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
| Maintains | Chardan Capital: Neutral | 8/16/2022 |
Related Tickers
RADX Radiopharm Theranostics Limited
4.5200
-5.83%
MLYS Mineralys Therapeutics, Inc.
12.51
-7.54%
ALMS Alumis Inc.
9.92
+16.16%
DWTX Dogwood Therapeutics, Inc.
4.1950
+0.36%
TECX Tectonic Therapeutic, Inc.
15.60
-6.42%
ICCC ImmuCell Corporation
5.37
-0.19%
MNPR Monopar Therapeutics Inc.
31.11
-10.06%
ADVM Adverum Biotechnologies, Inc.
3.8400
-2.54%
SEPN Septerna, Inc.
5.38
-7.24%
PULM Pulmatrix, Inc.
5.45
-8.86%